patent.fyi
Applications  /  US 2026/0355171
United States Patent Application Publication

US 2026/0355171 A1

Published
Nov 12, 2026
Filed
Aug 7, 2023
Earliest date on the face
Aug 5, 2022
Classification
A61K 31/4545
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Sulfur linked methyl group

What ifWhat if R1 were a methylthio group attached through sulfur?
Claim language“optionally substituted C1-6 alkoxy”

A thioether connects the scaffold to a terminal methyl group through a divalent sulfur atom. The sulfur is more polarizable than oxygen and changes the interaction of the substituent with nearby groups.

1.2Directly attached cyano group

What ifWhat if R2 were a cyano group attached through its carbon atom?
Claim language“optionally substituted C1-6 alkyl”

The scaffold forms a single bond to the carbon of a carbon–nitrogen triple bond. The triple bond holds the substituent in a linear geometry and places a hydrogen bond acceptor at its tip.

1.3Acyclic branched alkyl group

What ifWhat if R3 were a directly attached tert-butyl group?
Claim language“optionally substituted C6-18 aryl”

The scaffold bonds directly to a carbon bearing three methyl groups. The three branches provide a compact hydrophobic surface with a tetrahedral geometry.

1.4Separate groups on one carbon

What ifWhat if R2 and R3 were fluorine and cyclopropyl attached separately to the same carbon?
Claim language“form an optionally substituted C6-18 aryl”

The shared carbon forms separate single bonds to fluorine and to one carbon of the cyclopropyl ring. The three-membered ring constrains the shape of the R3 branch, and the carbon–fluorine bond supplies a local dipole.

1.6Acyclic terminal amide

What ifWhat if R5 were a primary carboxamide attached through its carbonyl carbon?
Claim language“optionally substituted 5- to 18-membered heteroaryl”

The alkylene linker terminates in a —C(=O)NH2 group. The carbonyl oxygen accepts a hydrogen bond, and the amide nitrogen donates one.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Specific version of a part

Fluorine at the R4 site

R4 is a fluorine atom connected by a single bond at the indicated scaffold position. The carbon–fluorine bond provides a local dipole with a single-atom substituent.

Carbon at the X site

X is carbon with the connections and bond orders assigned to that position in the scaffold. Any remaining valence is filled by hydrogen.

Nitrogen at the Y site

Y is nitrogen bonded to the adjacent scaffold atoms at the designated position. The local bond orders and valence determine its hydrogen count and formal charge.

Oxygen at the Z site

Z is divalent oxygen. The oxygen forms two single bonds to neighboring scaffold atoms and carries two lone pairs.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2006/0293328 A1
Published
Dec 28, 2006
Filed
May 17, 2006
Class
A61K 31/505
Document BUS 2009/0258871 A1
Published
Oct 15, 2009
Filed
Nov 10, 2006
Class
A61K 31/5377
Claim 1
Document A
Document B
1.1R1 is selected from the group consisting of H, hydroxy, optionally substituted C1-6 alkyl, —NH2, —C(O)—NH2, optionally substituted —C(O)—C1-6 alkyl, halogen, —C(OH)—NH2, —C(O)—OH, —CH2—NH2, —C(O)H and optionally substituted C1-6 alkoxy
L1, and L2 are selected from the group consisting of: wherein: R11, R12, R13, R14, R15, and R20 are each independently selected from the group consisting of H, alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, hydroxyalkyl, hydroxycycloalkyl, alkoxycycloalkyl, aminoalkyl, acyloxyl, alkylaminoalkyl, and alkoxycarbonyl; or R11, and R12 together represent a C2 to C10 alkyl, C2 to C10 hydroxyalkyl, or a C2 to C10 alkylene; or R 11 and R12 t
A · US 2006/0293328 A1 · ¶ 75
R1, R2 and R5 are independently selected from: a hydrogen atom, a lower alkyl group, an aralkyl group, and an aryl group;
B · US 2009/0258871 A1 · claim 23
1.2R2 is selected from the group consisting of H, ═O, hydroxy, halogen, optionally substituted C1-6 alkyl and optionally substituted C1-6 alkoxy
L1, and L2 are selected from the group consisting of: wherein: R11, R12, R13, R14, R15, and R20 are each independently selected from the group consisting of H, alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, hydroxyalkyl, hydroxycycloalkyl, alkoxycycloalkyl, aminoalkyl, acyloxyl, alkylaminoalkyl, and alkoxycarbonyl; or R11, and R12 together represent a C2 to C10 alkyl, C2 to C10 hydroxyalkyl, or a C2 to C10 alkylene; or R 11 and R12 t
A · US 2006/0293328 A1 · ¶ 75
R1, R2 and R5 are independently selected from: a hydrogen atom, a lower alkyl group, an aralkyl group, and an aryl group;
B · US 2009/0258871 A1 · claim 23
1.3R3 is selected from the group consisting of optionally substituted C6-18 aryl, optionally substituted 5- to 18-membered heteroaryl, optionally substituted C5-18 cycloalkyl, optionally substituted 5- to 18-membered heterocycloalkyl, or —C1-6 alkylene-R5
L1, and L2 are selected from the group consisting of: wherein: R11, R12, R13, R14, R15, and R20 are each independently selected from the group consisting of H, alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, hydroxyalkyl, hydroxycycloalkyl, alkoxycycloalkyl, aminoalkyl, acyloxyl, alkylaminoalkyl, and alkoxycarbonyl; or R11, and R12 together represent a C2 to C10 alkyl, C2 to C10 hydroxyalkyl, or a C2 to C10 alkylene; or R 11 and R12 t
A · US 2006/0293328 A1 · ¶ 75
R3, R4, R30 and R40 are independently selected from: a hydrogen atom, a hydroxyl group, a lower alkyl group, an aralkyl group, and an aryl group;
B · US 2009/0258871 A1 · claim 23
1.4or R2 and R3 together with the carbon atom to which they are attached form an optionally substituted C6-18 aryl, optionally substituted 5- to 18-membered heteroaryl, optionally substituted C5-18 cycloalkyl and optionally substituted 5- to 18-membered heterocycloalkyl
L1, and L2 are selected from the group consisting of: wherein: R11, R12, R13, R14, R15, and R20 are each independently selected from the group consisting of H, alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, hydroxyalkyl, hydroxycycloalkyl, alkoxycycloalkyl, aminoalkyl, acyloxyl, alkylaminoalkyl, and alkoxycarbonyl; or R11, and R12 together represent a C2 to C10 alkyl, C2 to C10 hydroxyalkyl, or a C2 to C10 alkylene; or R 11 and R12 t
A · US 2006/0293328 A1 · ¶ 75
1.5R4 is selected from the group consisting of H, ═O, hydroxy, halogen, optionally substituted C1-6 alkyl and optionally substituted C1-6 alkoxy
L1, and L2 are selected from the group consisting of: wherein: R11, R12, R13, R14, R15, and R20 are each independently selected from the group consisting of H, alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, hydroxyalkyl, hydroxycycloalkyl, alkoxycycloalkyl, aminoalkyl, acyloxyl, alkylaminoalkyl, and alkoxycarbonyl; or R11, and R12 together represent a C2 to C10 alkyl, C2 to C10 hydroxyalkyl, or a C2 to C10 alkylene; or R 11 and R12 t
A · US 2006/0293328 A1 · ¶ 75
R3, R4, R30 and R40 are independently selected from: a hydrogen atom, a hydroxyl group, a lower alkyl group, an aralkyl group, and an aryl group;
B · US 2009/0258871 A1 · claim 23
1.6R5 is selected from the group consisting of optionally substituted C6-18 aryl, optionally substituted 5- to 18-membered heteroaryl, optionally substituted C5-18 cycloalkyl and optionally substituted 5- to 18-membered heterocycloalkyl
L1, and L2 are selected from the group consisting of: wherein: R11, R12, R13, R14, R15, and R20 are each independently selected from the group consisting of H, alkyl, substituted alkyl, cycloalkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, hydroxyalkyl, hydroxycycloalkyl, alkoxycycloalkyl, aminoalkyl, acyloxyl, alkylaminoalkyl, and alkoxycarbonyl; or R11, and R12 together represent a C2 to C10 alkyl, C2 to C10 hydroxyalkyl, or a C2 to C10 alkylene; or R 11 and R12 t
A · US 2006/0293328 A1 · ¶ 75
R1, R2 and R5 are independently selected from: a hydrogen atom, a lower alkyl group, an aralkyl group, and an aryl group;
B · US 2009/0258871 A1 · claim 23
1.7m is 0 or 1
1.8X is selected from the group consisting of C and N
A compound of the formula (I): wherein: X, Y, Z and W each independently are selected from: a methine group optionally having substituents selected from a substituent group α; and a nitrogen atom; provided that where X, Y, Z and W all represent a methine group optionally having substituents selected from a substituent group α is excluded;
B · US 2009/0258871 A1 · claim 23
1.9Y is selected from the group consisting of C and N
A compound of the formula (I): wherein: X, Y, Z and W each independently are selected from: a methine group optionally having substituents selected from a substituent group α; and a nitrogen atom; provided that where X, Y, Z and W all represent a methine group optionally having substituents selected from a substituent group α is excluded;
B · US 2009/0258871 A1 · claim 23
1.10Z is selected from the group consisting of C, O, N and S
A compound of the formula (I): wherein: X, Y, Z and W each independently are selected from: a methine group optionally having substituents selected from a substituent group α; and a nitrogen atom; provided that where X, Y, Z and W all represent a methine group optionally having substituents selected from a substituent group α is excluded;
B · US 2009/0258871 A1 · claim 23
1.11wherein the compound is other than a compound of Formula IV, V, VII, VIII, IX, XI or XII:

An empty cell means only that no passage was reproduced there.

Statements in these documents
Thus, there continues to be a need for improvement in the art for additional compounds having desirable antimicrobial activity, whether against the representative pathogens referenced above or against other pathogens.
A · US 2006/0293328 A1 · ¶ 60
The presently disclosed subject matter relates to methods for combating microbial infections with novel dicationic terphenyl compounds and their aza analogues, processes for synthesizing novel dicationic terphenyl compounds and their aza analogues, and the novel dicationic terphenyl compounds and their aza analogues themselves.
A · US 2006/0293328 A1 · ¶ 2
Cite aspatent.fyi, US 2026/0355171 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355171/, SHA-256 7fbf387cb02d0d6a2e7a7383c794eea6d29b3cc49e6edfa485dff7696cbf2e6c
First published
Permanent addresshttps://patent.fyi/US20260355171/
Content fingerprint (SHA-256)7fbf387cb02d0d6a2e7a7383c794eea6d29b3cc49e6edfa485dff7696cbf2e6c
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi